Gasporox AB (publ)
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers Instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha… Read more
Gasporox AB (publ) (GPX) - Net Assets
Latest net assets as of September 2025: Skr18.86 Million SEK
Based on the latest financial reports, Gasporox AB (publ) (GPX) has net assets worth Skr18.86 Million SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr46.68 Million) and total liabilities (Skr27.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr18.86 Million |
| % of Total Assets | 40.41% |
| Annual Growth Rate | 29.58% |
| 5-Year Change | -21.66% |
| 10-Year Change | 516.71% |
| Growth Volatility | 285.29 |
Gasporox AB (publ) - Net Assets Trend (2013–2024)
This chart illustrates how Gasporox AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Gasporox AB (publ) (2013–2024)
The table below shows the annual net assets of Gasporox AB (publ) from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr26.69 Million | +15.09% |
| 2023-12-31 | Skr23.19 Million | -5.10% |
| 2022-12-31 | Skr24.44 Million | -14.64% |
| 2021-12-31 | Skr28.63 Million | -15.98% |
| 2020-12-31 | Skr34.07 Million | +3.35% |
| 2019-12-31 | Skr32.97 Million | +23.38% |
| 2018-12-31 | Skr26.72 Million | +85.87% |
| 2017-12-31 | Skr14.38 Million | -14.23% |
| 2016-12-31 | Skr16.76 Million | +287.22% |
| 2015-12-31 | Skr4.33 Million | +971.29% |
| 2014-12-31 | Skr404.00K | -73.82% |
| 2013-12-31 | Skr1.54 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Gasporox AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7441859500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr4.68 Million | 17.52% |
| Other Comprehensive Income | Skr21.77 Million | 81.54% |
| Other Components | Skr82.37 Million | 308.61% |
| Total Equity | Skr26.69 Million | 100.00% |
Gasporox AB (publ) Competitors by Market Cap
The table below lists competitors of Gasporox AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wahana Pronatural
JK:WAPO
|
$2.25 Million |
|
XWELL Inc.
NASDAQ:XWEL
|
$2.25 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
$2.26 Million |
|
Noronex Ltd
AU:NRX
|
$2.26 Million |
|
Ronin Resources Ltd
AU:RON
|
$2.25 Million |
|
Avalon GloboCare Corp.
NASDAQ:ALBT
|
$2.25 Million |
|
Wellard Ltd
AU:WLD
|
$2.25 Million |
|
JV SPAC Acquisition Corp. Right
NASDAQ:JVSAR
|
$2.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gasporox AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 23,191,000 to 26,691,000, a change of 3,500,000 (15.1%).
- Net loss of 2,676,000 reduced equity.
- Share repurchases of 57,000 reduced equity.
- New share issuances of 57,000 increased equity.
- Other comprehensive income increased equity by 21,764,000.
- Other factors decreased equity by 15,588,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-2.68 Million | -10.03% |
| Share Repurchases | Skr57.00K | -0.21% |
| Share Issuances | Skr57.00K | +0.21% |
| Other Comprehensive Income | Skr21.76 Million | +81.54% |
| Other Changes | Skr-15.59 Million | -58.4% |
| Total Change | Skr- | 15.09% |
Book Value vs Market Value Analysis
This analysis compares Gasporox AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.44x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.40x to 2.44x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | Skr0.79 | Skr7.42 | x |
| 2014-12-31 | Skr0.21 | Skr7.42 | x |
| 2015-12-31 | Skr2.19 | Skr7.42 | x |
| 2016-12-31 | Skr4.85 | Skr7.42 | x |
| 2017-12-31 | Skr3.01 | Skr7.42 | x |
| 2018-12-31 | Skr4.20 | Skr7.42 | x |
| 2019-12-31 | Skr4.72 | Skr7.42 | x |
| 2020-12-31 | Skr4.42 | Skr7.42 | x |
| 2021-12-31 | Skr3.33 | Skr7.42 | x |
| 2022-12-31 | Skr2.84 | Skr7.42 | x |
| 2023-12-31 | Skr2.70 | Skr7.42 | x |
| 2024-12-31 | Skr3.04 | Skr7.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gasporox AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.85%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 1.50x
- Recent ROE (-10.03%) is above the historical average (-114.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -158.26% | -636.76% | 0.12x | 2.13x | Skr-2.60 Million |
| 2014 | -954.06% | -304.68% | 0.24x | 13.02x | Skr-3.89 Million |
| 2015 | -81.15% | -289.05% | 0.21x | 1.31x | Skr-3.94 Million |
| 2016 | -22.45% | -168.14% | 0.11x | 1.22x | Skr-5.44 Million |
| 2017 | -37.29% | -102.05% | 0.26x | 1.40x | Skr-6.51 Million |
| 2018 | -27.54% | -100.57% | 0.20x | 1.38x | Skr-8.62 Million |
| 2019 | -24.38% | -70.29% | 0.26x | 1.35x | Skr-10.12 Million |
| 2020 | -12.81% | -35.04% | 0.30x | 1.21x | Skr-7.77 Million |
| 2021 | -18.83% | -34.26% | 0.42x | 1.31x | Skr-8.25 Million |
| 2022 | -18.65% | -21.25% | 0.48x | 1.82x | Skr-7.00 Million |
| 2023 | -5.37% | -3.96% | 0.72x | 1.88x | Skr-3.57 Million |
| 2024 | -10.03% | -7.85% | 0.85x | 1.50x | Skr-5.35 Million |
Industry Comparison
This section compares Gasporox AB (publ)'s net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $164,215,514
- Average return on equity (ROE) among peers: -30.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gasporox AB (publ) (GPX) | Skr18.86 Million | -158.26% | 1.47x | $2.25 Million |
| EmbeddedArt Group AB (EMART) | $31.34 Million | -57.16% | 0.68x | $7.23K |
| Insplorion AB (INSP) | $26.23 Million | -74.96% | 0.20x | $392.94K |
| Ngenic AB (NGENIC) | $37.98 Million | -51.98% | 0.70x | $28.84K |
| QSYS (QSYS) | $163.72 Million | 24.33% | 0.58x | $46.25 Million |
| Sensys Gatso Group AB (SGG) | $561.80 Million | 5.80% | 0.42x | $34.65 Million |